Stanley Roberts

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 781 citations

The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · The Journal of Clinical Pharmacology · 2003 · 309 citations

Drug Interactions, Preclinical Drug Evaluation, Biochemistry +14

Strategy for genotoxicity testing—Metabolic considerations

Warren W. Ku, Anita Bigger, Giovanni Brambilla et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2006 · 111 citations

Medicine, Toxicology Testing, Genotoxicity Testing—metabolic Considerations +4

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

Gondi Kumar, Venkata Jayanti, Marianne K. Johnson et al. · Pharmaceutical Research · 2004 · 105 citations

Medicine, Human Retrovirus, Antiviral Drug Development +7

Biological activity and in vivo clearance of anti-tumor antibody/cytokine fusion proteins

Stephen D. Gillies, Delano V. Young, Kin Ming Lo et al. · Bioconjugate Chemistry · 1993 · 95 citations

Laboratory Immunology, Immunology, Immunoediting +21